Syneos Health Inc. (SYNH)
NASDAQ: SYNH
· Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Sep 27, 2023, 10:00 PM
Syneos Health Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|
| Clinical Solutions Segment Revenue | 4.07B | 4.01B | 3.31B | 3.42B | 3.21B | 1.46B |
| Clinical Solutions Segment Revenue Growth | +1.54% | +21.24% | -3.36% | +6.55% | +119.95% | n/a |
| Commercial Solutions Segment Revenue | 1.32B | 1.2B | 1.11B | 1.25B | 1.18B | 392.88M |
| Commercial Solutions Segment Revenue Growth | +9.85% | +8.55% | -11.58% | +6.39% | +200.07% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 680.39M | 594.16M | 465.12M | 2.93B | 375.35M | 174.34M | 27.72M | 19.74M | 23.41M |
| Asia Pacific Revenue Growth | +14.51% | +27.75% | -84.13% | +680.60% | +115.29% | +529.00% | +40.39% | -15.65% | n/a |
| Emea Revenue | 1.33B | 140.79M | 99.1M | 444.82M | 955.88M | 458.26M | 200.8M | 223.27M | 215.84M |
| Emea Revenue Growth | +848.08% | +42.07% | -77.72% | -53.47% | +108.59% | +128.22% | -10.06% | +3.44% | n/a |
| Latin America Revenue | 151.66M | 3.14B | 2.79B | 1.06B | 84.55M | 45.77M | 11K | 200K | 23K |
| Latin America Revenue Growth | -95.18% | +12.64% | +164.60% | +1147.75% | +84.73% | +416009.09% | -94.50% | +769.57% | n/a |
| North America Revenue | 3.23B | 2.95B | 2.64B | 96.38M | 2.97B | 1.17B | 801.81M | 671.53M | 570.46M |
| North America Revenue Growth | +9.36% | +11.74% | +2639.13% | -96.76% | +153.25% | +46.48% | +19.40% | +17.72% | n/a |
| United States Revenue | 3.02B | n/a | n/a | 3.08B | 2.82B | 1.13B | 777.8M | 650.1M | 567.3M |
| United States Revenue Growth | n/a | n/a | n/a | +9.21% | +149.98% | +45.04% | +19.64% | +14.60% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 182.52M | 161.52M | 137.69M | 130.35M | 139.04M | 140.17M | 149.26M | 139.52M | 144.67M | 137.31M | 108.44M | 111.1M | 104.98M | 117.97M | 112.42M | 109.86M | 110.88M | 113.12M | 109.89M | 96.94M | 100.22M | 99.26M | 106.3M | 88.86M | 42.53M | 44.93M | 44.57M | 41.74M | 42.6M | 43.48M | 43.26M | 40.43M | 37.13M | 35.8M |
| Selling, General, and Administrative Revenue Growth | +13.01% | +17.30% | +5.63% | -6.25% | -0.80% | -6.09% | +6.98% | -3.56% | +5.36% | +26.62% | -2.39% | +5.83% | -11.01% | +4.94% | +2.33% | -0.92% | -1.98% | +2.94% | +13.35% | -3.27% | +0.97% | -6.62% | +19.63% | +108.92% | -5.35% | +0.82% | +6.77% | -2.00% | -2.03% | +0.52% | +6.99% | +8.90% | +3.70% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |